European Journal of Medical Genetics

European Journal of Medical Genetics - ISSN 1769-7212
Source Normalized Impact per Paper (SNIP): 1.021 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 0.896 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.708 (2020) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 2.643 (2020) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volume 1
Issues: 12 issues
ISSN: 17697212

Institutional Subscription

Sales tax will be calculated at check-out Price includes VAT/GST

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


The European Journal of Medical Genetics (EJMG) is a peer-reviewed journal that publishes articles in English on various aspects of human and medical genetics, the genetics of experimental models and developmental anomalies.

Original clinical and experimental research articles, short clinical reports and review articles are welcome on topics such as:

  • Clinical genetics and genomics, including neurodevelopmental disorders and single or multiple malformations syndromes and dysmorphology;
  • Inherited predisposition to cancer: rare inherited cancer predisposition syndromes and biology and pathophysiology of inherited cancers;
  • Fetal medicine and prenatal diagnosis, including prenatal diagnosis, prenatal screening, fetal therapies and teratology;
  • Diagnostic methods including sequencing studies (gene level), transcriptome studies, methylome and other Omics technologies, variant interpretation and functional validation;
  • Bioinformatics and statistical methods in genetics;
  • Personalized Medicine and therapies, including gene therapy and gene editing, non-genetic treatment of genetic disease, pharmacogenetics and genomics, theranostics and clinical trials;
  • Molecular biology and pathophysiology of genetic and genomic diseases: biology of cell, pathways and systems, epigenetics and gene regulation, biology and pathophysiology of specific genes and non-coding DNA;
  • Genetics and variants in populations: carrier screening, population genetics, evolutionary genetics, genetic epidemiology of diseases, genome variation and architecture in normal population;
  • Formal genetics: Mendelian and non-Mendelian inheritance;
  • Polygenic/ multifactorial disorders: association studies in large cohorts and risk evaluation in polygenic disorders;
  • Genetics and society: ethical aspects in genetics, impact of genomic medicine on public and patients, legal and reglementary aspects in genetics and clinical research, psychosocial aspects, rare diseases and genetics;
  • Teaching and training in genetics;
  • Genetic counselling;
  • Internet resources in Genetics.

Please note: tumor genetics and studies focusing on multifactorial diseases are not in the scope of the Journal.